0.53 USD
↗ 0.03 (6.71%)PRE MARKET (AS OF 04:03 AM EDT)
aTyr Pharma, Inc. Common Stock
ATYRNASDAQ • USD
Market: OPEN
aTyr Pharma, Inc. Common Stock (ATYR) is currently trading at $0.53. ATYR shows a split signal: technical indicators suggest "Buy" while underlying fundamentals indicate "Sell". Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. Valuation metrics place ATYR at a fair price relative to peers.
Technical & fundamental data as of Aug 4, 2026.
Open?$0.52
High?$0.53
Low?$0.52
Prev. Close?$0.49
Volume?147
Avg. Volume?1.8M
VWAP?$0.52
Rel. Volume?0.00x
Bid / Ask
Bid?$0.45 × 100
Ask?$0.61 × 100
Spread?$0.16
Midpoint?$0.53
Valuation & Ratios
Market Cap?52.0M
Shares Out?98.1M
Float?96.4M
Float %?98.4%
P/E Ratio?N/A
P/B Ratio?0.90
EPS?-$0.71
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
aTyr Pharma Inc is a clinical-stage biotechnology company focused on developing therapies for fibrosis and inflammatory conditions. Its research leverages tRNA synthetase biology to identify potential therapeutic targets. The company's discovery platform uses a proprietary library of domains derived from tRNA synthetases to explore signaling pathways. Its flagship clinical candidate, efzofitimod, is a novel biologic immunomodulatory in development for the treatment of interstitial lung disease (ILD).
Employees
58
Market Cap
48.2M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2015-05-07
Address
10240 SORRENTO VALLEY ROAD
SAN DIEGO, CA 92121
Phone: (858) 731-8389
SAN DIEGO, CA 92121
Phone: (858) 731-8389
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?▲ Bullish(+3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?50
Short Sent.?50
Piotroski F-Score?0/9Weak
Altman Z-Score?-11.61Distress
Confidence?48%Low
Short InterestElevated
Short % of Float?8.58%Elevated
Short Interest?8.3M
Days to Cover?4.3
Free Float96.4M
Avg Daily Volume1.9M
Settlement Date2026-07-15
Financial Health
Current Ratio?5.78Strong
Quick Ratio?5.78Strong
Cash Ratio?0.86Adequate
Debt/Equity?0.01Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?0.90CHEAP▾
Peers100
S&P97
P/S?273.51HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-0.6CHEAP▾
S&P97
EV/Sales?224.77HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?-120.9%WEAK▾
S&P3
ROA?-87.9%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-59298000
Enterprise Value?$42.7M
Fundamentals ratios updated end of day